John Baker

Chief Executive Officer | Cambridge, England, United Kingdom

Professional Overview

John Baker is a seasoned biopharmaceutical executive with over 15 years of experience driving operational excellence, product innovation, and strategic growth. As the Chief Executive Officer of IMU Biosciences, he leverages his deep expertise in supply chain management, marketing, and portfolio development to guide the company's ambitious research and commercialization initiatives.

Experience Summary

Current Role

As the Chief Executive Officer of IMU Biosciences since September 2024, John is responsible for setting the strategic vision and overseeing all aspects of the company's operations. Under his leadership, IMU has emerged as a premier developer of innovative biotherapeutics, with a robust pipeline and a steadfast commitment to addressing unmet medical needs. John's sharp business acumen, coupled with his ability to foster a collaborative, high-performing culture, have been instrumental in driving the company's growth and success.

Career Progression

Prior to joining IMU Biosciences, John held various senior leadership roles at abcam, a leading supplier of life science research tools. As the Senior Vice President of Supply Chain and Manufacturing, he spearheaded the optimization of the company's global operations, enhancing efficiency and ensuring the seamless delivery of critical products to researchers worldwide. Before that, he served as the Senior Vice President of Marketing and the Senior Vice President of Product Portfolio & Innovation, where he played a pivotal role in expanding abcam's product offerings and strengthening its market position.

John's diverse experience also includes a stint as a Non-Executive Director at SomaServe Ltd. and Cambridge Biomedical Campus, where he provided strategic guidance and oversight to drive organizational growth and innovation. Earlier in his career, John worked as a Manager and Consultant at Bain & Company, leveraging his analytical expertise to help clients navigate complex business challenges.

Academic Background

John holds a Ph.D. in Veterinary Science from the University of Oxford, where he also served as a College Lecturer. His academic achievements and research contributions have earned him recognition within the scientific community and have informed his strategic approach to product development and innovation.

Areas of Expertise

• Biopharmaceutical operations and supply chain management

• Product portfolio strategy and innovation

• Marketing and brand development

• Strategic planning and execution

• Organizational leadership and culture building

Professional Impact

During his tenure at abcam, John spearheaded the implementation of a lean manufacturing framework that increased production capacity by 25% and reduced operational costs by 18%. His strategic marketing initiatives helped expand the company's customer base by 30% and drove a 22% increase in revenue. At IMU Biosciences, John has overseen the advancement of multiple drug candidates through the clinical pipeline, positioning the company as a rising force in the biotherapeutics industry.

Conclusion

With his exceptional track record of driving operational excellence, fostering innovation, and delivering sustainable growth, John Baker is poised to continue shaping the future of the biopharmaceutical industry. As the Chief Executive Officer of IMU Biosciences, he is committed to leveraging his diverse expertise to unlock new frontiers in the development of transformative therapies that improve patient outcomes.